| Year |
Title |
Altmetric |
| 2023
|
WHO 2022 classification of penile and scrotal cancers: updates and evolution.
Histopathology.
82:508-520.
2023
|
|
| 2023
|
Identification of androgen response-related lncRNAs in prostate cancer
2023
|
|
| 2023
|
Reply to Yongbao Wei, Haijian Huang, and Liefu Ye's Letter to the Editor re: George J. Netto, Mahul B. Amin, Daniel M. Berney, et al. The 2022 World Health Organization Classification of Tumors of the Urinary System and Male Genital Organs—Part B: Prostate and Urinary Tract Tumors. Eur Urol. 2022;82:469–82..
European Urology.
83:e16-e17.
2023
|
|
| 2022
|
A tribute to Prof. Ondrej Hes, MD, PhD (1968-2022).
Modern Pathology.
35:2023-2024.
2022
|
|
| 2022
|
NCCN GUIDELINES® INSIGHTS: Prostate Cancer, Version 1.2023: Featured Updates to the NCCN Guidelines.
Journal of the National Comprehensive Cancer Network : JNCCN.
20:1288-1298.
2022
|
|
| 2022
|
TFE3 and TFEB-rearranged renal cell carcinomas: an immunohistochemical panel to differentiate from common renal cell neoplasms
2022
|
|
| 2022
|
The 2022 World Health Organization Classification of Tumors of the Urinary System and Male Genital Organs—Part B: Prostate and Urinary Tract Tumors.
European Urology.
82:469-482.
2022
|
|
| 2022
|
The 2022 World Health Organization Classification of Tumours of the Urinary System and Male Genital Organs—Part A: Renal, Penile, and Testicular Tumours.
European Urology.
82:458-468.
2022
|
|
| 2022
|
What's new in WHO fifth edition – urinary tract.
Histopathology.
81:439-446.
2022
|
|
| 2022
|
ARID1A-deficient bladder cancer is dependent on PI3K signaling and sensitive to EZH2 and PI3K inhibitors.
JCI Insight.
7.
2022
|
|
| 2022
|
High-fat diet promotes prostate cancer growth through histamine signaling.
International Journal of Cancer.
151:623-636.
2022
|
|
| 2022
|
Comparison of three validated PD-L1 immunohistochemical assays in urothelial carcinoma of the bladder: interchangeability and issues related to patient selection.
Frontiers in Immunology.
13.
2022
|
|
| 2022
|
GPNMB expression identifies TSC1/2/mTOR-associated and MiT family translocation-driven renal neoplasms
2022
|
|
| 2022
|
Meta-analysis of the robustness of COVID-19 diagnostic kit performance during the early pandemic.
BMJ Open.
12.
2022
|
|
| 2022
|
Correction to: Performance of novel non-invasive urine assay UroSEEK in cohorts of equivocal urine cytology (Virchows Archiv, (2020), 476, 3, (423-429), 10.1007/s00428-019-02654-1)
2022
|
|
| 2022
|
TSC loss is a clonal event in eosinophilic solid and cystic renal cell carcinoma: a multiregional tumor sampling study.
Modern Pathology.
35:376-385.
2022
|
|
| 2022
|
UALCAN: An update to the integrated cancer data analysis platform.
Neoplasia.
25:18-27.
2022
|
|
| 2022
|
BCG invokes superior STING-mediated innate immune response over radiotherapy in a carcinogen murine model of urothelial cancer
2022
|
|
| 2022
|
News in the classification of WHO 2022 bladder tumors
2022
|
|
| 2022
|
Testicular Germ-Cell Tumors with Spermatic Cord Involvement: A Retrospective International Multi-Institutional Experience.
Modern Pathology.
35:249-255.
2022
|
|
| 2022
|
An introduction to the WHO 5th edition 2022 classification of testicular tumours.
Histopathology.
2022
|
|
| 2022
|
Preface
2022
|
|
| 2022
|
Programmed cell death-ligand 1 expression in different molecular subtypes of upper tract urothelial carcinoma.
International Journal of Urology.
29:89-90.
2022
|
|
| 2022
|
Spindle Cell Sarcoma of the Uterus Harboring MEIS1::NCOA1 Fusion Gene and Mimicking Endometrial Stromal Sarcoma.
International Journal of Surgical Pathology.
2022
|
|
| 2022
|
WHO 2022 landscape of papillary and chromophobe renal cell carcinoma.
Histopathology.
2022
|
|
| 2022
|
WHO Classification of Tumours fifth edition: evolving issues in the classification, diagnosis, and prognostication of prostate cancer.
Histopathology.
2022
|
|
| 2021
|
Vascular architectural patterns in clear cell renal cell carcinoma and clear cell papillary renal cell carcinoma
2021
|
|
| 2021
|
Diagnostic utility of one-stop fusion gene panel to detect TFE3/TFEB gene rearrangement and amplification in renal cell carcinomas.
Modern Pathology.
34:2055-2063.
2021
|
|
| 2021
|
Androgen receptor signaling induces cisplatin resistance via down-regulating gulp1 expression in bladder cancer.
International Journal of Molecular Sciences.
22.
2021
|
|
| 2021
|
Molecular Pathology of Urothelial Carcinoma.
Surgical Pathology Clinics.
14:403-414.
2021
|
|
| 2021
|
Gut microbiota–derived short-chain fatty acids promote prostate cancer growth via IGF1 signaling.
Cancer Research.
81:4014-4026.
2021
|
|
| 2021
|
Clinical Application of TERT Promoter Mutations in Urothelial Carcinoma.
Frontiers in Oncology.
11.
2021
|
|
| 2021
|
New developments in existing WHO entities and evolving molecular concepts: The Genitourinary Pathology Society (GUPS) update on renal neoplasia.
Modern Pathology.
34:1392-1424.
2021
|
|
| 2021
|
Telomerase reverse transcriptase promoter mutation in tumorigenesis of bladder cancer: Evolutionary trajectory by algorithmic inference from cross-sectional data.
International Journal of Urology.
28:774-776.
2021
|
|
| 2021
|
The Genitourinary Pathology Society Update on Classification and Grading of Flat and Papillary Urothelial Neoplasia with New Reporting Recommendations and Approach to Lesions with Mixed and Early Patterns of Neoplasia.
Advances in Anatomic Pathology.
28:179-195.
2021
|
|
| 2021
|
The Genitourinary Pathology Society Update on Classification of Variant Histologies, T1 Substaging, Molecular Taxonomy, and Immunotherapy and PD-L1 Testing Implications of Urothelial Cancers.
Advances in Anatomic Pathology.
28:196-208.
2021
|
|
| 2021
|
Novel, emerging and provisional renal entities: The Genitourinary Pathology Society (GUPS) update on renal neoplasia.
Modern Pathology.
34:1167-1184.
2021
|
|
| 2021
|
Impact of PD-L1 and PD-1 Expression on the Prognostic Significance of CD8+ Tumor-Infiltrating Lymphocytes in Non-Small Cell Lung Cancer.
Frontiers in Immunology.
12.
2021
|
|
| 2021
|
Cathepsin k: A novel diagnostic and predictive biomarker for renal tumors.
Cancers.
13.
2021
|
|
| 2021
|
Correction to: Novel, emerging and provisional renal entities: the Genitourinary Pathology Society (GUPS) update on renal neoplasia (Modern Pathology, (2021), 10.1038/s41379-021-00737-6).
Modern Pathology.
34:1037.
2021
|
|
| 2021
|
Diagnostic approach in TFE3-rearranged renal cell carcinoma: A multi-institutional international survey
2021
|
|
| 2021
|
Practice patterns related to prostate cancer grading: results of a 2019 Genitourinary Pathology Society clinician survey.
Urologic Oncology: seminars and original investigations.
39:295.e1-295.e8.
2021
|
|
| 2021
|
TFEB rearranged renal cell carcinoma. A clinicopathologic and molecular study of 13 cases. Tumors harboring MALAT1-TFEB, ACTB-TFEB, and the novel NEAT1-TFEB translocations constantly express PDL1.
Modern Pathology.
34:842-850.
2021
|
|
| 2021
|
The 2019 genitourinary pathology society (GUPS) white paper on contemporary grading of prostate cancer.
Archives of Pathology and Laboratory Medicine.
145:461-493.
2021
|
|
| 2021
|
Clinical Restaging and Tumor Sequencing are Inaccurate Indicators of Response to Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer[Formula presented].
European Urology.
79:364-371.
2021
|
|
| 2021
|
Identification of BXDC2 as a key downstream effector of the androgen receptor in modulating cisplatin sensitivity in bladder cancer.
Cancers.
13:1-13.
2021
|
|
| 2021
|
Molecular biomarker testing in localized prostate cancer the critical role of pathologists.
Archives of Pathology and Laboratory Medicine.
145:264-265.
2021
|
|
| 2021
|
Well-differentiated neuroendocrine tumors of the lower urinary tract: biologic behavior of a rare entity.
Human Pathology.
109:53-58.
2021
|
|
| 2021
|
Prostate cancer, version 1.2021: Featured updates to the nccn guidelines.
Journal of the National Comprehensive Cancer Network : JNCCN.
19:134-143.
2021
|
|
| 2021
|
Meta-Analysis of Robustness of COVID-19 Diagnostic Kits During Early Pandemic.
2021
|
|
| 2021
|
ARID1A-mutant and deficient bladder cancer is sensitive to EZH2 pharmacologic inhibition
2021
|
|
| 2021
|
Diagnosis of "cribriform" prostatic adenocarcinoma: an interobserver reproducibility study among urologic pathologists with recommendations..
American Journal of Cancer Research.
11:3990-4001.
2021
|
|
| 2020
|
Rare MDM2 amplification in a fat-predominant angiomyolipoma
2020
|
|
| 2020
|
Re: Therapeutically Actionable PAK4 is Amplified, Overexpressed, and Involved in Bladder Cancer Progression.
Investigative urology.
204:622-623.
2020
|
|
| 2020
|
Expression of nectin-4 and pd-l1 in upper tract urothelial carcinoma.
International Journal of Molecular Sciences.
21:1-13.
2020
|
|
| 2020
|
GULP1 regulates the NRF2-KEAP1 signaling axis in urothelial carcinoma.
Science Signaling.
13.
2020
|
|
| 2020
|
Immune checkpoint status and tumor microenvironment in vulvar squamous cell carcinoma
2020
|
|
| 2020
|
Erratum: Acute kidney injury promotes development of papillary renal cell adenoma and carcinoma from renal progenitor cells (Science Translation Medicine (2020) 12:536 (eaaw6003) DOI: 10.1126/scitranslmed.aaw6003).
Science Translational Medicine.
12.
2020
|
|
| 2020
|
The role of adipocytokines and their receptors in bladder cancer: Expression of adiponectin or leptin is an independent prognosticator.
American Journal of Translational Research.
12:3033-3045.
2020
|
|
| 2020
|
Clinical Significance of Hotspot Mutation Analysis of Urinary Cell-Free DNA in Urothelial Bladder Cancer.
Frontiers in Oncology.
10.
2020
|
|
| 2020
|
Therapeutically actionable PAK4 is amplified, overexpressed, and involved in bladder cancer progression.
Oncogene.
39:4077-4091.
2020
|
|
| 2020
|
Reporting practices and resource utilization in the era of intraductal carcinoma of the prostate: A survey of genitourinary subspecialists.
American Journal of Surgical Pathology.
44:673-680.
2020
|
|
| 2020
|
FOXO1 as a tumor suppressor inactivated via AR/ERβ signals in urothelial cells.
Endocrine-Related Cancer.
27:231-244.
2020
|
|
| 2020
|
Acute kidney injury promotes development of papillary renal cell adenoma and carcinoma from renal progenitor cells.
Science Translational Medicine.
12.
2020
|
|
| 2020
|
Performance of novel non-invasive urine assay UroSEEK in cohorts of equivocal urine cytology
2020
|
|
| 2020
|
Editorial.
Modern Pathology.
33:178.
2020
|
|
| 2020
|
Tumour immune microenvironment in primary and metastatic papillary renal cell carcinoma.
Histopathology.
76:423-432.
2020
|
|
| 2020
|
Editorial comment: A modified clinicopathological tumor staging system for survival prediction of patients with penile cancer.
International Brazilian Journal of Urology.
46:275-276.
2020
|
|
| 2020
|
The Ever Changing Landscape of Anatomic Pathology Practice.
Advances in Anatomic Pathology.
27:1-2.
2020
|
|
| 2020
|
Updates on the Genomics of Bladder Cancer and Novel Molecular Taxonomy.
Advances in Anatomic Pathology.
27:36-43.
2020
|
|
| 2019
|
Expression and Role of Methylenetetrahydrofolate Dehydrogenase 1 Like (MTHFD1L) in Bladder Cancer.
Translational Oncology.
12:1416-1424.
2019
|
|
| 2019
|
Characterization of glycine-N-acyltransferase like 1 (GLYATL1) in prostate cancer
2019
|
|
| 2019
|
Incidence and distribution of UroSEEK gene panel in a multi-institutional cohort of bladder urothelial carcinoma.
Modern Pathology.
32:1544-1550.
2019
|
|
| 2019
|
Immunohistochemical assessment of basal and luminal markers in non-muscle invasive urothelial carcinoma of bladder
2019
|
|
| 2019
|
Therapeutically actionable PAK4 is amplified, overexpressed and involved in bladder cancer progression
2019
|
|
| 2019
|
Characterization of glycine-N-acyltransferase like 1 (GLYATL1) in prostate cancer
2019
|
|
| 2019
|
PD-L1 expression in non–small cell lung cancer: evaluation of the diagnostic accuracy of a laboratory-developed test using clone E1L3N in comparison with 22C3 and SP263 assays.
Human Pathology.
90:54-59.
2019
|
|
| 2019
|
Tumor immune microenvironment in non–muscle-invasive urothelial carcinoma of the bladder.
Human Pathology.
89:24-32.
2019
|
|
| 2019
|
Clinical implication of the mammalian target of rapamycin pathway in upper tract urothelial carcinoma with negative GATA binding protein 3 expression.
International Journal of Urology.
26:678-679.
2019
|
|
| 2019
|
Diagnostic potential of TERT promoter and FGFR3 mutations in urinary cell-free DNA in upper tract urothelial carcinoma.
Cancer Science.
110:1771-1779.
2019
|
|
| 2019
|
INSL3 Expression in Leydig Cell Hyperplasia and Leydig Cell Tumors.
Applied Immunohistochemistry and Molecular Morphology.
27:203-209.
2019
|
|
| 2019
|
Rare case of squamous cell carcinoma arising from tunica vaginalis in a background of chronic hydrocele.
Urology Case Reports.
23:55-57.
2019
|
|
| 2019
|
Re: Assessing cancer progression and stable disease after neoadjuvant chemotherapy for organ-confined muscle-invasive bladder cancer.
Investigative urology.
201:441.
2019
|
|
| 2019
|
Targeted sequencing of plasmacytoid urothelial carcinoma reveals frequent TERT promoter mutations.
Human Pathology.
85:1-9.
2019
|
|
| 2019
|
p53 Is a Master Regulator of Proteostasis in SMARCB1-Deficient Malignant Rhabdoid Tumors.
Cancer Cell.
35:204-220.e9.
2019
|
|
| 2019
|
Expression of programmed cell death ligand 1 in non–small cell lung cancer: Comparison between cytologic smears, core biopsies, and whole sections using the SP263 assay.
Cancer Cytopathology.
127:52-61.
2019
|
|
| 2019
|
Insulin-like growth factor-1 receptor expression in upper tract urothelial carcinoma
2019
|
|
| 2019
|
Prostate cancer, version 2.2019.
Journal of the National Comprehensive Cancer Network : JNCCN.
17:479-505.
2019
|
|
| 2018
|
Correction: PD-L1 expression heterogeneity in non-small cell lung cancer: evaluation of small biopsies reliability..
Oncotarget.
9:37077.
2018
|
|
| 2018
|
Correction: PD-L1 expression heterogeneity in non-small cell lung cancer: Evaluation of small biopsies reliability (Oncotarget (2017) 8 (90123-90131) DOI: 10.18632/oncotarget.21485).
Oncotarget.
9:37077.
2018
|
|
| 2018
|
Wnt receptor Frizzled 8 is a target of ERG in prostate cancer
2018
|
|
| 2018
|
A modified clinicopathological tumor staging system for survival prediction of patients with penile cancer ChiCTR16008041 ChiCTR 11 Medical and Health Sciences 1112 Oncology and Carcinogenesis.
Chinese journal of cancer.
38.
2018
|
|
| 2018
|
Erratum: Correction: Non-invasive detection of urothelial cancer through the analysis of driver gene mutations and aneuploidy (eLife (2018) 7 PII: e43237).
eLife.
7.
2018
|
|
| 2018
|
Genito-urinary genomics and emerging biomarkers for immunomodulatory cancer treatment.
Seminars in Cancer Biology.
52:216-227.
2018
|
|
| 2018
|
PD-L1 Assays 22C3 and SP263 are Not Interchangeable in Non-Small Cell Lung Cancer When Considering Clinically Relevant Cutoffs.
American Journal of Surgical Pathology.
42:1384-1389.
2018
|
|
| 2018
|
Hypomethylation, endogenous retrovirus expression, and interferon signaling in testicular germ cell tumors
2018
|
|
| 2018
|
A Role for De Novo Purine Metabolic Enzyme PAICS in Bladder Cancer Progression.
Neoplasia.
20:894-904.
2018
|
|
| 2018
|
Eosinophilic solid and cystic (ESC) renal cell carcinomas harbor tsc mutations: Molecular analysis supports an expanding clinicopathologic spectrum.
American Journal of Surgical Pathology.
42:1166-1181.
2018
|
|
| 2018
|
High-fat diet-induced inflammation accelerates prostate cancer growth via IL6 signaling.
Clinical Cancer Research.
24:4309-4318.
2018
|
|
| 2018
|
PD-L1 Expression Heterogeneity in Non–Small Cell Lung Cancer: Defining Criteria for Harmonization between Biopsy Specimens and Whole Sections.
Journal of Thoracic Oncology.
13:1113-1120.
2018
|
|
| 2018
|
Iatrogenic pathology of the urinary bladder.
Seminars in Diagnostic Pathology.
35:218-227.
2018
|
|
| 2018
|
PD-L1 expression comparison between primary and relapsed non-small cell lung carcinoma using whole sections and clone SP263.
Oncotarget.
9:30465-30471.
2018
|
|
| 2018
|
Single 15-Min Protocol Yields the Same Cryoablation Size and Margin as the Conventional 10–8–10-Min Protocol: Results of Kidney and Liver Swine Experiment.
Cardiovascular and Interventional Radiology.
41:1089-1094.
2018
|
|
| 2018
|
miR-34a regulates expression of the stathmin-1 oncoprotein and prostate cancer progression.
Molecular Cancer Research.
16:1125-1137.
2018
|
|
| 2018
|
Comprehensive Evaluation of Programmed Death-Ligand 1 Expression in Primary and Metastatic Prostate Cancer.
American Journal of Pathology.
188:1478-1485.
2018
|
|
| 2018
|
Nuclear factor-kb promotes urothelial tumorigenesis and cancer progression via cooperation with androgen receptor signaling.
Molecular Cancer Therapeutics.
17:1303-1314.
2018
|
|
| 2018
|
Reduced immunohistochemical PTEN staining is associated with higher progression rate and recurrence episodes in non-invasive low-grade papillary urothelial carcinoma of the bladder
2018
|
|
| 2018
|
Prognostic impact of concomitant loss of PBRM1 and BAP1 protein expression in early stages of clear cell renal cell carcinoma.
Urologic Oncology: seminars and original investigations.
36:243.e1-243.e8.
2018
|
|
| 2018
|
Non-invasive detection of urothelial cancer through the analysis of driver gene mutations and aneuploidy.
eLife.
7.
2018
|
|
| 2018
|
Re-evaluation of 33 ‘unclassified’ eosinophilic renal cell carcinomas in young patients.
Histopathology.
72:588-600.
2018
|
|
| 2018
|
ATF2 promotes urothelial cancer outgrowth via cooperation with androgen receptor signaling.
Endocrine Connections.
7:1397-1408.
2018
|
|
| 2018
|
Prostaglandin receptors induce urothelial tumourigenesis as well as bladder cancer progression and cisplatin resistance presumably via modulating PTEN expression.
British Journal of Cancer.
118:213-223.
2018
|
|
| 2018
|
YAP1 and COX2 coordinately regulate urothelial cancer stem-like cells.
Cancer Research.
78:168-181.
2018
|
|
| 2017
|
AIM1 is an actin-binding protein that suppresses cell migration and micrometastatic dissemination.
Nature Communications.
8.
2017
|
|
| 2017
|
Prostate Cancer: An Update on Molecular Pathology with Clinical Implications.
European Urology Supplements.
16:253-271.
2017
|
|
| 2017
|
Spectrum of genetic mutations in de novo PUNLMP of the urinary bladder
2017
|
|
| 2017
|
Pathology Imagebase—a reference image database for standardization of pathology.
Histopathology.
71:677-685.
2017
|
|
| 2017
|
Non-invasive detection of bladder cancer through the analysis of driver gene mutations and aneuploidy
2017
|
|
| 2017
|
Non-invasive detection of upper tract urothelial carcinomas through the analysis of driver gene mutations and aneuploidy in urine
2017
|
|
| 2017
|
MicroRNAs, promising biomarkers in the diagnosis of Xp11 translocation RCC—reply.
Human Pathology.
68:206-207.
2017
|
|
| 2017
|
MicroRNA expression profiling of Xp11 renal cell carcinoma.
Human Pathology.
67:18-29.
2017
|
|
| 2017
|
Analytic, preanalytic, and clinical validation of p53 IHC for detection of TP53 missense mutation in prostate cancer.
Clinical Cancer Research.
23:4693-4703.
2017
|
|
| 2017
|
Preparing pathology for the molecular era
2017
|
|
| 2017
|
Toward personalized management in bladder cancer: the promise of novel molecular taxonomy
2017
|
|
| 2017
|
Intravesical BCG Induces CD4+ T-cell expansion in an immune competent model of bladder cancer.
Cancer Immunology Research.
5:594-603.
2017
|
|
| 2017
|
A phase II trial of dovitinib in BCG-unresponsive urothelial carcinoma with FGFR3 mutations or overexpression: Hoosier Cancer Research Network trial HCRN 12-157.
Clinical Cancer Research.
23:3003-3011.
2017
|
|
| 2017
|
GATA3 immunohistochemistry in urothelial carcinoma of the upper urinary tract as a urothelial marker and a prognosticator.
Human Pathology.
64:83-90.
2017
|
|
| 2017
|
Strong association of insulin-like growth factor 1 receptor expression with histologic grade, subtype, and HPV status in penile squamous cell carcinomas: a tissue microarray study of 112 cases
2017
|
|
| 2017
|
Comprehensive Determination of Prostate Tumor ETS Gene Status in Clinical Samples Using the CLIA Decipher Assay
2017
|
|
| 2017
|
Assessing Cancer Progression and Stable Disease After Neoadjuvant Chemotherapy for Organ-confined Muscle-invasive Bladder Cancer.
Urology.
102:148-158.
2017
|
|
| 2017
|
Characterization of urinary extracellular vesicle proteins in muscle-invasive bladder cancer.
Oncotarget.
8:91199-91208.
2017
|
|
| 2017
|
Immune-checkpoint status in penile squamous cell carcinoma: a North American cohort.
Human Pathology.
59:55-61.
2017
|
|
| 2017
|
Lymph node density predicts recurrence and death after inguinal lymph node dissection for penile cancer.
Investigative and Clinical Urology.
58:20-25.
2017
|
|
| 2017
|
PD-L1 expression heterogeneity in non-small cell lung cancer: Evaluation of small biopsies reliability.
Oncotarget.
8:90123-90131.
2017
|
|
| 2017
|
Pathologic response in patients receiving neoadjuvant chemotherapy for muscle-invasive bladder cancer: Is therapeutic effect owing to chemotherapy or TURBT?.
Urologic Oncology: seminars and original investigations.
35:34.e17-34.e25.
2017
|
|
| 2017
|
Urological cancer related to familial syndromes.
International Brazilian Journal of Urology.
43:192-201.
2017
|
|
| 2016
|
Expression of steroid hormone receptors and its prognostic significance in urothelial carcinoma of the upper urinary tract.
Cancer Biology and Therapy.
17:1188-1196.
2016
|
|
| 2016
|
SPINK1 Defines a Molecular Subtype of Prostate Cancer in Men with More Rapid Progression in an at Risk, Natural History Radical Prostatectomy Cohort.
Investigative urology.
196:1436-1444.
2016
|
|
| 2016
|
Circulating Tumor DNA as a Marker of Therapeutic Response in Patients With Renal Cell Carcinoma: A Pilot Study.
Clinical Genitourinary Cancer.
14:e515-e520.
2016
|
|
| 2016
|
Clinical mutational profiling of bone metastases of lung and colon carcinoma and malignant melanoma using next-generation sequencing.
Cancer Cytopathology.
124:744-753.
2016
|
|
| 2016
|
High prevalence of TERT promoter mutations in micropapillary urothelial carcinoma
2016
|
|
| 2016
|
TFEB-amplified renal cell carcinomas.
American Journal of Surgical Pathology.
40:1484-1495.
2016
|
|
| 2016
|
Current concepts in the diagnosis and pathobiology of intraepithelial neoplasia: A review by organ system.
CA: A Cancer Journal for Clinicians.
66:408-436.
2016
|
|
| 2016
|
For staining of ALK protein, the novel D5F3 antibody demonstrates superior overall performance in terms of intensity and extent of staining in comparison to the currently used ALK1 antibody
2016
|
|
| 2016
|
Gleason grade 4 prostate adenocarcinoma patterns: an interobserver agreement study among genitourinary pathologists.
Histopathology.
69:441-449.
2016
|
|
| 2016
|
The intratumoral balance between metabolic and immunologic gene expression is associated with anti-PD-1 response in patients with renal cell carcinoma.
Cancer Immunology Research.
4:726-733.
2016
|
|
| 2016
|
Blood Transfusion is Associated with Increased Perioperative Morbidity and Adverse Oncologic Outcomes in Bladder Cancer Patients Receiving Neoadjuvant Chemotherapy and Radical Cystectomy.
Annals of Surgical Oncology.
23:2715-2722.
2016
|
|
| 2016
|
High-resolution telomere fluorescence in situ hybridization reveals intriguing anomalies in germ cell tumors.
Human Pathology.
54:106-112.
2016
|
|
| 2016
|
The utility of STAT6 and ALDH1 expression in the differential diagnosis of solitary fibrous tumor versus prostate-specific stromal neoplasms.
Human Pathology.
54:184-188.
2016
|
|
| 2016
|
ZKSCAN3 promotes bladder cancer cell proliferation, migration, and invasion.
Oncotarget.
7:53599-53610.
2016
|
|
| 2016
|
Detection of TERT promoter mutations in primary adenocarcinoma of the urinary bladder.
Human Pathology.
53:8-13.
2016
|
|
| 2016
|
Extent of renal vein invasion influences prognosis in patients with renal cell carcinoma.
BJU International.
118:112-117.
2016
|
|
| 2016
|
Overexpression of Insulin-like Growth Factor-1 Receptor Is Associated with Penile Cancer Progression.
Urology.
92:51-56.
2016
|
|
| 2016
|
Role for anti-PD-L1 immune checkpoint inhibitor in advanced urothelial carcinoma
2016
|
|
| 2016
|
The ratio of CD8 to Treg tumor-infiltrating lymphocytes is associated with response to cisplatin-based neoadjuvant chemotherapy in patients with muscle invasive urothelial carcinoma of the bladder.
OncoImmunology.
5.
2016
|
|
| 2016
|
High prevalence of TERT promoter mutations in primary squamous cell carcinoma of the urinary bladder.
Modern Pathology.
29:511-515.
2016
|
|
| 2016
|
Test feasibility of next-generation sequencing assays in clinical mutation detection of small biopsy and fine needle aspiration specimens.
American Journal of Clinical Pathology.
145:696-702.
2016
|
|
| 2016
|
A Retrospective Analysis of the Effect on Survival of Time from Diagnosis to Neoadjuvant Chemotherapy to Cystectomy for Muscle Invasive Bladder Cancer.
Investigative urology.
195:880-885.
2016
|
|
| 2016
|
A right atrial mass: "more than meets the eye".
Journal of Clinical Oncology.
34:e49-e50.
2016
|
|
| 2016
|
Cyclosporine A and tacrolimus inhibit urothelial tumorigenesis.
Molecular Carcinogenesis.
55:161-169.
2016
|
|
| 2016
|
Emerging Bladder Cancer Biomarkers and Targets of Therapy.
Urologic Clinics of North America.
43:63-76.
2016
|
|
| 2016
|
Germline variants in asporin vary by race, modulate the tumor microenvironment, and are differentially associated with metastatic prostate cancer.
Clinical Cancer Research.
22:448-458.
2016
|
|
| 2016
|
Clinical validation of the 2005 isup gleason grading system in a cohort of intermediate and high risk men undergoing radical prostatectomy.
PLoS One.
11.
2016
|
|
| 2016
|
Frequent BRAF V600E mutations in metanephric stromal tumor.
American Journal of Surgical Pathology.
40:719-722.
2016
|
|
| 2016
|
Global 5-Hydroxymethylcytosine Levels Are Profoundly Reduced in Multiple Genitourinary Malignancies.
PLoS One.
11.
2016
|
|
| 2016
|
Molecular Diagnostics for Precision Medicine in Colorectal Cancer: Current Status and Future Perspective.
BioMed Research International.
2016.
2016
|
|
| 2016
|
Significance of a minor high-grade component in a low-grade noninvasive papillary urothelial carcinoma of bladder.
Human Pathology.
47:20-25.
2016
|
|
| 2016
|
TFE3-fusion variant analysis defines specific clinicopathologic associations among Xp11 translocation cancers.
American Journal of Surgical Pathology.
40:723-737.
2016
|
|
| 2016
|
The 2014 international society of urological pathology (ISUP) consensus conference on gleason grading of prostatic carcinoma definition of grading patterns and proposal for a new grading system.
American Journal of Surgical Pathology.
40:244-252.
2016
|
|
| 2016
|
Tissue-based Genomics Augments Post-prostatectomy Risk Stratification in a Natural History Cohort of Intermediate- and High-Risk Men.
European Urology.
69:157-165.
2016
|
|
| 2015
|
Cyclin D1 Loss Distinguishes Prostatic Small-Cell Carcinoma from Most Prostatic Adenocarcinomas.
Clinical Cancer Research.
21:5619-5629.
2015
|
|
| 2015
|
Renal carcinoma associated with a novel succinate dehydrogenase A mutation: A case report and review of literature of a rare subtype of renal carcinoma.
Human Pathology.
46:1951-1955.
2015
|
|
| 2015
|
Erratum: Identification and validation of protein biomarkers of response to neoadjuvant platinum chemotherapy in muscle invasive urothelial carcinoma (PLoS ONE (2015) 10:7 (e0131245) (DOI:10.1371/journal.pone.0131245)).
PLoS One.
10.
2015
|
|
| 2015
|
Androgen-regulated SPARCL1 in the tumor microenvironment inhibits metastatic progression.
Cancer Research.
75:4322-4334.
2015
|
|
| 2015
|
PTEN loss and ERG protein expression are infrequent in prostatic ductal adenocarcinomas and concurrent acinar carcinomas
2015
|
|
| 2015
|
Identification and validation of Protein biomarkers of response to neoadjuvant platinum chemotherapy in muscle invasive urothelial carcinoma.
PLoS One.
10.
2015
|
|
| 2015
|
18F-DCFBC PET/CT for PSMA-based detection and characterization of primary prostate cancer.
Journal of Nuclear Medicine.
56:1003-1010.
2015
|
|
| 2015
|
Smooth muscle and adenoma-like renal tumor: A previously unreported variant of mixed epithelial stromal tumor or a distinctive renal neoplasm?.
Human Pathology.
46:894-905.
2015
|
|
| 2015
|
Update for the practicing pathologist: The International Consultation On Urologic Disease-European association of urology consultation on bladder cancer.
Modern Pathology.
28:612-630.
2015
|
|
| 2015
|
Gemcitabine and cisplatin neoadjuvant chemotherapy for muscle-invasive urothelial carcinoma: Predicting response and assessing outcomes.
Urologic Oncology: seminars and original investigations.
33:204.e1-204.e7.
2015
|
|
| 2015
|
Immunohistochemical expression of ARID1A in penile squamous cell carcinomas: A tissue microarray study of 112 cases.
Human Pathology.
46:761-766.
2015
|
|
| 2015
|
Human papillomavirus infection and immunohistochemical p16INK4a expression as predictors of outcome in penile squamous cell carcinomas.
Human Pathology.
46:532-540.
2015
|
|
| 2015
|
Assessment of tumoral PD-L1 expression and intratumoral CD8+ T cells in urothelial carcinoma.
Urology.
85:703.e1-703.e6.
2015
|
|
| 2015
|
Involvement of epigenetics and EMT-related miRNA in arsenic-induced neoplastic transformation and their potential clinical use.
Cancer Prevention Research.
8:208-221.
2015
|
|
| 2015
|
Primary renal sclerosing epithelioid fibrosarcoma: Report of 2 cases with EWSR1-CREB3L1 gene fusion.
American Journal of Surgical Pathology.
39:365-373.
2015
|
|
| 2015
|
GATA-3 expression in trophoblastic tissues: An immunohistochemical study of 445 cases, including diagnostic utility.
American Journal of Surgical Pathology.
39:101-108.
2015
|
|
| 2015
|
Cyclin A1 expression predicts progression in pT1 urothelial carcinoma of bladder: A tissue microarray study of 149 patients treated by transurethral resection.
Histopathology.
66:262-269.
2015
|
|
| 2015
|
Cyclosporine A and tacrolimus inhibit bladder cancer growth through down-regulation of NFATc1.
Oncotarget.
6:1582-1593.
2015
|
|
| 2015
|
ELK1 is up-regulated by androgen in bladder cancer cells and promotes tumor progression.
Oncotarget.
6:29860-29876.
2015
|
|
| 2015
|
Grade Heterogeneity in Small Renal Masses: Potential Implications for Renal Mass Biopsy.
Investigative urology.
193:36-40.
2015
|
|
| 2015
|
Molecular Updates in Prostate Cancer.
Surgical Pathology Clinics.
8:561-580.
2015
|
|
| 2015
|
Prognostic role and implications of mutation status of tumor suppressor gene ARID1A in cancer: A systematic review and meta-analysis.
Oncotarget.
6:39088-39097.
2015
|
|
| 2015
|
Utility of uroplakin II expression as a marker of urothelial carcinoma.
Human Pathology.
46:58-64.
2015
|
|
| 2014
|
ARID1A immunohistochemistry improves outcome prediction in invasive urothelial carcinoma of urinary bladder.
Human Pathology.
45:2233-2239.
2014
|
|
| 2014
|
GSTP1 promoter methylation is associated with recurrence in early stage prostate cancer.
Investigative urology.
192:1542-1548.
2014
|
|
| 2014
|
Preliminary evaluation of urinary soluble Met as a Biomarker for urothelial carcinoma of the bladder.
Journal of Translational Medicine.
12.
2014
|
|
| 2014
|
Pathological characteristics and radiographic correlates of complex renal cysts.
Urologic Oncology: seminars and original investigations.
32:1010-1016.
2014
|
|
| 2014
|
Reduced glucocorticoid receptor expression predicts bladder tumor recurrence and progression.
American Journal of Clinical Pathology.
142:157-164.
2014
|
|
| 2014
|
High frequency of TERT promoter mutation in small cell carcinoma of bladder, but not in small cell carcinoma of other origins.
Journal of Hematology and Oncology.
7.
2014
|
|
| 2014
|
Rb loss is characteristic of prostatic small cell neuroendocrine carcinoma.
Clinical Cancer Research.
20:890-903.
2014
|
|
| 2014
|
Detection of circulating tumor DNA in early- and late-stage human malignancies.
Science Translational Medicine.
6.
2014
|
|
| 2014
|
Combining routine morphology, p16INK4a immunohistochemistry, and in situ hybridization for the detection of human papillomavirus infection in penile carcinomas: A tissue microarray study using classifier performance analyses.
Urologic Oncology: seminars and original investigations.
32:171-177.
2014
|
|
| 2014
|
Comprehensive profile of GATA binding protein 3 immunohistochemical expression in primary and metastatic renal neoplasms.
Human Pathology.
45:244-248.
2014
|
|
| 2014
|
A comprehensive resequence-analysis of 250 kb region of 8q24.21 in men of African ancestry
2014
|
|
| 2014
|
An epigenetic marker panel for recurrence risk prediction of low grade papillary urothelial cell carcinoma (LGPUCC) and its potential use for surveillance after transurethral resection using urine.
Oncotarget.
5:5218-5233.
2014
|
|
| 2014
|
Biobanking of derivatives from radical retropubic and robot-assisted laparoscopic prostatectomy tissues as part of the prostate cancer biorepository network
2014
|
|
| 2014
|
Clear cell papillary renal cell carcinoma: Micro-RNA expression profiling and comparison with clear cell renal cell carcinoma and papillary renal cell carcinoma.
Human Pathology.
45:1130-1138.
2014
|
|
| 2014
|
Clinical heterogeneity of Xp11 translocation renal cell carcinoma: Impact of fusion subtype, age, and stage.
Modern Pathology.
27:875-886.
2014
|
|
| 2014
|
Epigenetic inactivation of VGF associated with Urothelial Cell Carcinoma and its potential as a non-invasive biomarker using urine.
Oncotarget.
5:3350-3361.
2014
|
|
| 2014
|
Estrogen receptor alpha prevents bladder cancer development via INPP4B inhibited Akt pathway in vitro and in vivo.
Oncotarget.
5:7917-7935.
2014
|
|
| 2014
|
Expression of UDP-glucuronosyltransferase 1A in bladder cancer: Association with prognosis and regulation by estrogen.
Molecular Carcinogenesis.
53:314-324.
2014
|
|
| 2014
|
GATA3 expression in small cell carcinoma of bladder and prostate and its potential role in determining primary tumor origin.
Human Pathology.
45:1682-1687.
2014
|
|
| 2014
|
High prevalence of screen detected prostate cancer in West Africans: Implications for racial disparity of prostate cancer.
Investigative urology.
192:730-736.
2014
|
|
| 2014
|
Immunohistochemical expression of the mammalian target of rapamycin pathway in penile squamous cell carcinomas: A tissue microarray study of 112 cases.
Histopathology.
64:863-871.
2014
|
|
| 2014
|
Insulin-like growth factor-1 receptor overexpression is associated with outcome in invasive urothelial carcinoma of urinary bladder: A retrospective study of patients treated using radical cystectomy.
Urology.
83:1444.e1-1444.e6.
2014
|
|
| 2014
|
Long interspersed element-1 protein expression is a hallmark of many human cancers.
American Journal of Pathology.
184:1280-1286.
2014
|
|
| 2014
|
Pharmacokinetics and toxicology of a fibroblast activation protein (FAP)-Activated prodrug in murine xenograft models of human cancer
2014
|
|
| 2014
|
Renal tumors: The International Society of Urologic Pathology (ISUP) 2012 consensus conference recommendations.
Annales de Pathologie.
34:448-461.
2014
|
|
| 2014
|
Sacrococcygeal teratomas: Clinico-pathological characteristics and isochromosome 12p status.
Modern Pathology.
27:562-568.
2014
|
|
| 2014
|
T(6;11) Renal cell carcinoma (RCC): Expanded immunohistochemical profile emphasizing novel RCC markers and report of 10 new genetically confirmed cases.
American Journal of Surgical Pathology.
38:604-614.
2014
|
|
| 2014
|
The utility of an extensive postchemotherapy staging evaluation in patients receiving neoadjuvant chemotherapy for bladder cancer.
Urology.
84:358-364.
2014
|
|
| 2014
|
VCL-ALK renal cell carcinoma in children with sickle-cell trait: The eighth sickle-cell nephropathy?.
American Journal of Surgical Pathology.
38:858-863.
2014
|
|
| 2013
|
TERT promoter mutations occur early in urothelial neoplasia and are biomarkers of early disease and disease recurrence in urine.
Cancer Research.
73:7162-7167.
2013
|
|
| 2013
|
Chromophobe renal cell carcinoma: Multiphase MDCT enhancement patterns and morphologic features.
American Journal of Roentgenology.
201:1268-1276.
2013
|
|
| 2013
|
Dysregulation of mammalian target of rapamycin pathway in upper tract urothelial carcinoma.
Human Pathology.
44:2668-2676.
2013
|
|
| 2013
|
Frequent truncating mutations of STAG2 in bladder cancer.
Nature Genetics.
45:1428-1430.
2013
|
|
| 2013
|
Immunohistochemical profile of the penile urethra and differential expression of GATA3 in urothelial versus squamous cell carcinomas of the penile urethra.
Human Pathology.
44:2760-2767.
2013
|
|
| 2013
|
The epidermal growth factor receptor is frequently overexpressed in penile squamous cell carcinomas: A tissue microarray and digital image analysis study of 112 cases.
Human Pathology.
44:2690-2695.
2013
|
|
| 2013
|
The role of GATA binding protein 3 in the differential diagnosis of collecting duct and upper tract urothelial carcinomas.
Human Pathology.
44:2651-2657.
2013
|
|
| 2013
|
Combined treatment effects of radiation and immunotherapy: Studies in an autochthonous prostate cancer model
2013
|
|
| 2013
|
Activation of mammalian target of rapamycin signaling pathway markers in minute adenocarcinoma of the prostate.
Urology.
82:1083-1089.
2013
|
|
| 2013
|
Molecular genetics and genomics progress in urothelial bladder cancer.
Seminars in Diagnostic Pathology.
30:313-320.
2013
|
|
| 2013
|
Performance models of infiltration within the sub-basin of the river Marcela, on the upper Rio Grande-MG.
Semina: Ciências Agrárias.
34:2589-2602.
2013
|
|
| 2013
|
Dysregulation of the mammalian target of rapamycin pathway in chromophobe renal cell carcinomas.
Human Pathology.
44:2323-2330.
2013
|
|
| 2013
|
Renal cell carcinoma presenting with brain metastasis from a 1.6 cm primary tumor
2013
|
|
| 2013
|
Relevance of the mammalian target of rapamycin pathway in the prognosis of patients with high-risk non-muscle invasive bladder cancer.
Human Pathology.
44:1766-1772.
2013
|
|
| 2013
|
Comparison of biochemical recurrence-free survival between periprostatic and pelvic lymph node metastases of prostate cancer.
International Journal of Surgical Pathology.
21:352-357.
2013
|
|
| 2013
|
Epidemiologic profile, sexual history, pathologic features, and human papillomavirus status of 103 patients with penile carcinoma.
World Journal of Urology.
31:861-867.
2013
|
|
| 2013
|
Utilization of a TFE3 break-apart FISH assay in a renal tumor consultation service.
American Journal of Surgical Pathology.
37:1150-1163.
2013
|
|
| 2013
|
Focal positive prostate-specific membrane antigen (PSMA) expression in ganglionic tissues associated with prostate neurovascular bundle: Implications for novel intraoperative PSMA-based fluorescent imaging techniques.
Urologic Oncology: seminars and original investigations.
31:572-575.
2013
|
|
| 2013
|
Immunohistochemical expression of SALL4 in hepatocellular carcinoma, a potential pitfall in the differential diagnosis of yolk sac tumors.
Human Pathology.
44:1293-1299.
2013
|
|
| 2013
|
Determination of the nonlethal margin inside the visible "ice-ball" during percutaneous cryoablation of renal tissue.
Cardiovascular and Interventional Radiology.
36:783-790.
2013
|
|
| 2013
|
Clinical applications of recent molecular advances in urologic malignancies: No longer chasing a "mirage"?.
Advances in Anatomic Pathology.
20:175-203.
2013
|
|
| 2013
|
Intrapancreatic accessory spleen: A case report and review of literature.
Diagnostic Cytopathology.
41:466-469.
2013
|
|
| 2013
|
TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal
2013
|
|
| 2013
|
Sequencing CTLA-4 blockade with cell-based immunotherapy for prostate cancer.
Journal of Translational Medicine.
11.
2013
|
|
| 2013
|
Dysregulation of mammalian target of rapamycin pathway in plasmacytoid variant of urothelial carcinoma of the urinary bladder.
Human Pathology.
44:612-622.
2013
|
|
| 2013
|
Genome-wide methylation profiling and the PI3K-AKT pathway analysis associated with smoking in urothelial cell carcinoma.
Cell Cycle.
12:1058-1070.
2013
|
|
| 2013
|
A broad survey of cathepsin k immunoreactivity in human neoplasms.
American Journal of Clinical Pathology.
139:151-159.
2013
|
|
| 2013
|
LMP2, a novel immunohistochemical marker to distinguish renal oncocytoma from the eosinophilic variant of chromophobe renal cell carcinoma.
Experimental and Molecular Pathology.
94:29-32.
2013
|
|
| 2013
|
Handling and staging of renal cell carcinoma: The International Society of Urological Pathology Consensus (ISUP) conference recommendations.
American Journal of Surgical Pathology.
37:1505-1517.
2013
|
|
| 2013
|
High levels of phosphatase and tensin homolog expression are associated with tumor progression, tumor recurrence, and systemic metastases in pt1 urothelial carcinoma of the bladder: A tissue microarray study of 156 patients treated by transurethral resection.
Urology.
81:116-122.
2013
|
|
| 2013
|
Renal tumors: Diagnostic and prognostic biomarkers.
American Journal of Surgical Pathology.
37:1518-1531.
2013
|
|
| 2013
|
The International Society of Urological Pathology (ISUP) Vancouver classification of renal neoplasia.
American Journal of Surgical Pathology.
37:1469-1489.
2013
|
|
| 2013
|
The International Society of Urological Pathology (ISUP) grading system for renal cell carcinoma and other prognostic parameters.
American Journal of Surgical Pathology.
37:1490-1504.
2013
|
|
| 2012
|
Immunoexpression status and prognostic value of mammalian target of rapamycin and hypoxia-induced pathway members in papillary cell renal cell carcinomas.
Human Pathology.
43:2129-2137.
2012
|
|
| 2012
|
Mechanism of growth inhibition of prostate cancer xenografts by valproic acid.
BioMed Research International.
2012.
2012
|
|
| 2012
|
Molecular Pathology of Bladder Cancer.
Surgical Pathology Clinics.
5:843-858.
2012
|
|
| 2012
|
Tissue expression of CD10 protein in colorectal carcinoma: Correlation with the anatomopathological features of the tumor and with lymph node and liver metastases.
Revista Brasilera de Coloproctologia.
32:34-39.
2012
|
|
| 2012
|
GATA binding protein 3 is down-regulated in bladder cancer yet strong expression is an independent predictor of poor prognosis in invasive tumor.
Human Pathology.
43:2033-2040.
2012
|
|
| 2012
|
Immunohistochemical expression of minichromosome maintenance complex protein 2 predicts biochemical recurrence in prostate cancer: A tissue microarray and digital imaging analysis-based study of 428 cases.
Human Pathology.
43:1852-1865.
2012
|
|
| 2012
|
Loss of PTEN expression is associated with increased risk of recurrence after prostatectomy for clinically localized prostate cancer.
Modern Pathology.
25:1543-1549.
2012
|
|
| 2012
|
High epidermal growth factor receptor immunohistochemical expression in urothelial carcinoma of the bladder is not associated with EGFR mutations in exons 19 and 21: A study using formalin-fixed, paraffin-embedded archival tissues.
Human Pathology.
43:1590-1595.
2012
|
|
| 2012
|
Molecular confirmation of t(6;11)(p21;q12) renal cell carcinoma in archival paraffin-embedded material using a break-apart TFEB FISH assay expands its clinicopathologic spectrum.
American Journal of Surgical Pathology.
36:1516-1526.
2012
|
|
| 2012
|
A 66-year-old man with prostate-specific antigen recurrence and lung mass after radical prostatectomy.
Urology.
80:247-249.
2012
|
|
| 2012
|
Distribution and characterization of subtypes of penile intraepithelial neoplasia and their association with invasive carcinomas: A pathological study of 139 lesions in 121 patients.
Human Pathology.
43:1020-1027.
2012
|
|
| 2012
|
Increased EZH2 protein expression is associated with invasive urothelial carcinoma of the bladder.
Urologic Oncology: seminars and original investigations.
30:428-433.
2012
|
|
| 2012
|
Thyroid transcription factor 1 expression in a case of renal collecting duct carcinoma - Reply.
Human Pathology.
43:1154.
2012
|
|
| 2012
|
Expression of androgen and oestrogen receptors and its prognostic significance in urothelial neoplasm of the urinary bladder.
BJU International.
109:1716-1726.
2012
|
|
| 2012
|
Prevalence of BPH and lower urinary tract symptoms in West Africans.
Prostate Cancer and Prostatic Diseases.
15:170-176.
2012
|
|
| 2012
|
Perivascular epithelioid cell tumors (PEComas) harboring TFE3 gene rearrangements lack the TSC2 alterations characteristic of conventional PEComas: Further evidence for a biological distinction.
American Journal of Surgical Pathology.
36:783-784.
2012
|
|
| 2012
|
Results of live donor liver transplantation in patients with hepatitic C virus infection: The HCV 3 trial experience.
Clinical Transplantation.
26:502-509.
2012
|
|
| 2012
|
Anti-tumor effects of endogenous prostate cancer-specific CD8 T cells in a murine TCR transgenic model
2012
|
|
| 2012
|
Emerging critical role of molecular testing in diagnostic genitourinary pathology.
Archives of Pathology and Laboratory Medicine.
136:372-390.
2012
|
|
| 2012
|
High-grade prostatic adenocarcinoma present in a single biopsy core is associated with increased extraprostatic extension, seminal vesicle invasion, and positive surgical margins at prostatectomy.
Urology.
79:863-868.
2012
|
|
| 2012
|
Immune inhibitory molecules LAG-3 and PD-1 synergistically regulate T-cell function to promote tumoral immune escape.
Cancer Research.
72:917-927.
2012
|
|
| 2012
|
Characteristics of positive surgical margins in robotic-assisted radical prostatectomy, open retropubic radical prostatectomy, and laparoscopic radical prostatectomy: A comparative histopathologic study from a single academic center.
Human Pathology.
43:254-260.
2012
|
|
| 2012
|
DNA methylation profiles delineate epigenetic heterogeneity in seminoma and non-seminoma.
British Journal of Cancer.
106:414-423.
2012
|
|
| 2012
|
High-grade papillary urothelial carcinoma of the urinary tract: A clinicopathologic analysis of a post-World Health Organization/International Society of Urological Pathology classification cohort from a single academic center.
Human Pathology.
43:115-120.
2012
|
|
| 2012
|
Immunohistochemical evidence of dysregulation of the mammalian target of rapamycin pathway in primary and metastatic pheochromocytomas.
Urology.
80:736.e7-736.e12.
2012
|
|
| 2012
|
Molecular biomarkers in urothelial carcinoma of the bladder: Are we there yet?.
Nature Reviews Urology.
9:41-51.
2012
|
|
| 2011
|
A randomized, multicenter study comparing steroid-free immunosuppression and standard immunosuppression for liver transplant recipients with chronic hepatitis C.
Liver Transplantation.
17:1394-1403.
2011
|
|
| 2011
|
Erratum: Expression status and prognostic significance of mammalian target of rapamycin pathway members in urothelial carcinoma of urinary bladder after cystectomy (Cancer (2010) 116 (5517-26)).
Cancer.
117:5021.
2011
|
|
| 2011
|
Hepatocyte nuclear factor-1β expression in clear cell adenocarcinomas of the bladder and urethra: Diagnostic utility and implications for histogenesis.
Human Pathology.
42:1613-1619.
2011
|
|
| 2011
|
Increased gene copy number of ERG on chromosome 21 but not TMPRSS2-ERG fusion predicts outcome in prostatic adenocarcinomas.
Modern Pathology.
24:1511-1520.
2011
|
|
| 2011
|
Papillary urothelial neoplasm of low malignant potential of the urinary bladder: clinicopathologic and outcome analysis from a single academic center.
Human Pathology.
42:1799-1803.
2011
|
|
| 2011
|
PTEN protein loss by immunostaining: Analytic validation and prognostic indicator for a high risk surgical cohort of prostate cancer patients.
Clinical Cancer Research.
17:6563-6573.
2011
|
|
| 2011
|
Humanizing π-class glutathione s-transferase regulation in a mouse model alters liver toxicity in response to acetaminophen overdose.
PLoS One.
6.
2011
|
|
| 2011
|
Differential expression of cathepsin K in neoplasms harboring TFE3 gene fusions.
Modern Pathology.
24:1313-1319.
2011
|
|
| 2011
|
Immunoexpression status and prognostic value of mtor and hypoxia-induced pathway members in primary and metastatic clear cell renal cell carcinomas.
American Journal of Surgical Pathology.
35:1549-1556.
2011
|
|
| 2011
|
Prevalence of the alternative lengthening of telomeres telomere maintenance mechanism in human cancer subtypes.
American Journal of Pathology.
179:1608-1615.
2011
|
|
| 2011
|
Diffuse expression of PAX2 and PAX8 in the cystic epithelium of mixed epithelial stromal tumor, angiomyolipoma with epithelial cysts, and primary renal synovial sarcoma: Evidence supporting renal tubular differentiation.
American Journal of Surgical Pathology.
35:1264-1273.
2011
|
|
| 2011
|
Should intervening benign tissue be included in the measurement of discontinuous foci of cancer on prostate needle biopsy? Correlation with radical prostatectomy findings.
International Brazilian Journal of Urology.
37:668-669.
2011
|
|
| 2011
|
Should intervening benign tissue be included in the measurement of discontinuous foci of cancer on prostate needle biopsy? correlation with radical prostatectomy findings.
American Journal of Surgical Pathology.
35:1351-1355.
2011
|
|
| 2011
|
Adrenal lymphangioma: Clinicopathologic and immunohistochemical characteristics of a rare lesion.
Human Pathology.
42:1013-1018.
2011
|
|
| 2011
|
High prevalence of polyclonal hypergamma-globulinemia in adult males in Ghana, Africa.
American Journal of Hematology.
86:554-558.
2011
|
|
| 2011
|
Immunohistochemistry for ERG expression as a surrogate for TMPRSS2-ERG fusion detection in prostatic adenocarcinomas.
American Journal of Surgical Pathology.
35:1014-1020.
2011
|
|
| 2011
|
An EGFR-ERK-SOX9 signaling cascade links urothelial development and regeneration to cancer.
Cancer Research.
71:3812-3821.
2011
|
|
| 2011
|
ERG gene rearrangements are common in prostatic small cell carcinomas.
Modern Pathology.
24:820-828.
2011
|
|
| 2011
|
Genome-wide analysis of genetic alterations in testicular primary seminoma using high resolution single nucleotide polymorphism arrays.
Genomics.
97:341-349.
2011
|
|
| 2011
|
Impact of surgical technique (open vs laparoscopic vs robotic-assisted) on pathological and biochemical outcomes following radical prostatectomy: An analysis using propensity score matching.
BJU International.
107:1956-1962.
2011
|
|
| 2011
|
Diagnostic use of PAX8, CAIX, TTF-1, and TGB in metastatic renal cell carcinoma of the thyroid.
American Journal of Surgical Pathology.
35:757-761.
2011
|
|
| 2011
|
Interobserver variability in histologic evaluation of radical prostatectomy between central and local pathologists: Findings of TAX 3501 multinational clinical trial.
Urology.
77:1155-1160.
2011
|
|
| 2011
|
Molecular diagnostics in urologic malignancies a work in progress.
Archives of Pathology and Laboratory Medicine.
135:610-621.
2011
|
|
| 2011
|
PAX2(-)/PAX8(-)/inhibin A(+) immunoprofile in hemangioblastoma: A helpful combination in the differential diagnosis with metastatic clear cell renal cellcarcinoma to the central nervous system.
American Journal of Surgical Pathology.
35:262-267.
2011
|
|
| 2011
|
Does valproic acid induce neuroendocrine differentiation in prostate cancer?.
BioMed Research International.
2011.
2011
|
|
| 2011
|
Distinctive immunohistochemical profile of penile intraepithelial lesions: A study of 74 cases.
American Journal of Surgical Pathology.
35:553-562.
2011
|
|
| 2011
|
Global 5-hydroxymethylcytosine content is significantly reduced in tissue stem/progenitor cell compartments and in human cancers.
Oncotarget.
2:627-637.
2011
|
|
| 2011
|
Immunohistochemical analysis of SMARCB1/INI-1 expression in collecting duct carcinoma.
Urology.
78:474.e1-474.e5.
2011
|
|
| 2011
|
Tumor volume threshold of insignificant prostate cancer-was Dr. Stamey Right all along?.
Investigative urology.
185:10-11.
2011
|
|
| 2010
|
Decreased expression of Cyr61 is associated with prostate cancer recurrence after surgical treatment.
Clinical Cancer Research.
16:5908-5913.
2010
|
|
| 2010
|
Expression status and prognostic significance of mammalian target of rapamycin pathway members in urothelial carcinoma of urinary bladder after cystectomy.
Cancer.
116:5517-5526.
2010
|
|
| 2010
|
A distinctive subset of PEComas harbors TFE3 gene fusions.
American Journal of Surgical Pathology.
34:1395-1406.
2010
|
|
| 2010
|
Prostate melanosis associated with acinar adenocarcinoma.
International Journal of Surgical Pathology.
18:379-380.
2010
|
|
| 2010
|
TMPRSS2-ERG fusion as a marker of prostatic lineage in small-cell carcinoma.
Histopathology.
57:633.
2010
|
|
| 2010
|
Xp11 translocation renal cell carcinoma (RCC): Extended immunohistochemical profile emphasizing novel RCC markers.
American Journal of Surgical Pathology.
34:1295-1303.
2010
|
|
| 2010
|
Androgen-induced TOP2B-mediated double-strand breaks and prostate cancer gene rearrangements.
Nature Genetics.
42:668-675.
2010
|
|
| 2010
|
Low-grade papillary urothelial carcinoma of the urinary bladder: A clinicopathologic analysis of a post-world Health Organization/International Society of Urological Pathology classification cohort from a single academic center.
Archives of Pathology and Laboratory Medicine.
134:1160-1163.
2010
|
|
| 2010
|
Low-grade papillary urothelial carcinoma of the urinary bladder: A clinicopathologic analysis of a post-world health organization/international society of urological pathology classification cohort from a single academic center.
International Brazilian Journal of Urology.
36:506-507.
2010
|
|
| 2010
|
PAX8 (+)/p63 (-) Immunostaining pattern in renal collecting duct carcinoma (CDC): A useful immunoprofile in the differential diagnosis of CDC versus urothelial carcinoma of upper urinary tract.
American Journal of Surgical Pathology.
34:965-969.
2010
|
|
| 2010
|
Renal medullary carcinoma: Molecular, pathological and clinical evidence for treatment with topoisomerase-inhibiting therapy.
BJU International.
106:62-65.
2010
|
|
| 2010
|
A pharmacodynamic study of rapamycin in men with intermediate- to high-risk localized prostate cancer.
Clinical Cancer Research.
16:3057-3066.
2010
|
|
| 2010
|
Reversible epithelial to mesenchymal transition and acquired resistance to sunitinib in patients with renal cell carcinoma: Evidence from a xenograft study.
Molecular Cancer Therapeutics.
9:1525-1535.
2010
|
|
| 2010
|
Conventional prostatic adenocarcinoma arising in a multilocular prostatic cystadenoma.
Pathology International.
60:413-416.
2010
|
|
| 2010
|
Extracellular Matrix Associated Protein CYR61 is Linked to Prostate Cancer Development.
Investigative urology.
183:1604-1610.
2010
|
|
| 2010
|
The Relationship of Vascular Endothelial Growth Factor and Coagulation Factor (Fibrin and Fibrinogen) Expression in Clear Cell Renal Cell Carcinoma.
Urology.
75:608-614.
2010
|
|
| 2010
|
Erratum: Non-invasive papillary urothelial neoplasms: The 2004 WHO/ISUP classification system (Pathology International (2010) 60:1 (18)).
Pathology International.
60:147.
2010
|
|
| 2010
|
Non-invasive papillary urothelial neoplasms: The 2004 WHO/ISUP classification system.
Pathology International.
60:1-8.
2010
|
|
| 2010
|
Theranostic and prognostic biomarkers: Genomic applications in urological malignancies.
Pathology.
42:384-394.
2010
|
|
| 2009
|
Identification of nuclear structural protein alterations associated with seminomas.
Journal of Cellular Biochemistry.
108:1274-1279.
2009
|
|
| 2009
|
TMPRSS2-ERG gene fusion status in minute (minimal) prostatic adenocarcinoma.
Modern Pathology.
22:1415-1422.
2009
|
|
| 2009
|
TMPRSS2-ERG gene fusions are infrequent in prostatic ductal adenocarcinomas.
Modern Pathology.
22:1399-1400.
2009
|
|
| 2009
|
PSMA expression in Schwannoma: A potential clinical mimicker of metastatic prostate carcinoma.
Urologic Oncology: seminars and original investigations.
27:525-528.
2009
|
|
| 2009
|
Cathepsin-K immunoreactivity distinguishes MiTF/TFE family renal translocation carcinomas from other renal carcinomas.
Modern Pathology.
22:1016-1022.
2009
|
|
| 2009
|
Topoisomerase II α Status in Renal Medullary Carcinoma: Immuno-Expression and Gene Copy Alterations of a Potential Target of Therapy.
Investigative urology.
182:735-740.
2009
|
|
| 2009
|
Comparison of gene expression profiles in tubulocystic carcinoma and collecting duct carcinoma of the kidney.
American Journal of Surgical Pathology.
33:1103-1106.
2009
|
|
| 2009
|
Specific detection of prostate cancer cells in urine by multiplex immunofluorescence cytology.
Human Pathology.
40:924-933.
2009
|
|
| 2009
|
Cyclophosphamide augments antitumor immunity: Studies in an autochthonous prostate cancer model.
Cancer Research.
69:4309-4318.
2009
|
|
| 2009
|
Phosphorylated H2AX in Noninvasive Low Grade Urothelial Carcinoma of the Bladder: Correlation With Tumor Recurrence.
Investigative urology.
181:1387-1392.
2009
|
|
| 2009
|
TMPRSS2-ERG gene fusions are infrequent in prostatic ductal adenocarcinomas.
Modern Pathology.
22:359-365.
2009
|
|
| 2009
|
Editorial Comment.
Urology.
74:1161-1162.
2009
|
|
| 2009
|
Editorial Comment.
Investigative urology.
181:1074-1075.
2009
|
|
| 2009
|
Multi-institutional validation of the predictive value of ki-67 labeling index in patients with urinary bladder cancer
2009
|
|
| 2009
|
p53 Predictive Value for pT1-2 N0 Disease at Radical Cystectomy.
Investigative urology.
182:907-913.
2009
|
|
| 2008
|
Benign Mimickers of Prostate Adenocarcinoma on Needle Biopsy and Transurethral Resection.
Surgical Pathology Clinics.
1:1-41.
2008
|
|
| 2008
|
Mesenchymal Tumors of the Prostate.
Surgical Pathology Clinics.
1:105-128.
2008
|
|
| 2008
|
Global DNA hypomethylation in intratubular germ cell neoplasia and seminoma, but not in nonseminomatous male germ cell tumors.
Modern Pathology.
21:1337-1344.
2008
|
|
| 2008
|
Papillary renal cell carcinoma with low-grade spindle cell foci: A mimic of mucinous tubular and spindle cell carcinoma.
American Journal of Surgical Pathology.
32:1353-1359.
2008
|
|
| 2008
|
Profiling the expression pattern of GPI transamidase complex subunits in human cancer.
Modern Pathology.
21:979-991.
2008
|
|
| 2008
|
Aggressive recurrent respiratory papillomatosis in a neonate.
International Journal of Pediatric Otorhinolaryngology.
72:917-920.
2008
|
|
| 2008
|
Increased spermine oxidase expression in human prostate cancer and prostatic intraepithelial neoplasia tissues
2008
|
|
| 2008
|
Prostatic adenocarcinoma in colorectal biopsy: clinical and pathologic features.
Human Pathology.
39:543-549.
2008
|
|
| 2008
|
Aberrant diffuse expression of p63 in adenocarcinoma of the prostate on needle biopsy and radical prostatectomy: Report of 21 cases.
American Journal of Surgical Pathology.
32:461-467.
2008
|
|
| 2008
|
Fat-predominant mixed epithelial stromal tumor (MEST): Report of a unique case mimicking angiomyolipoma.
International Journal of Surgical Pathology.
16:73-77.
2008
|
|
| 2007
|
Colorectal adenocarcinoma involving the prostate: report of 9 cases.
Human Pathology.
38:1836-1841.
2007
|
|
| 2007
|
Corticosteroid-free immunosuppression with daclizumab in HCV+ liver transplant recipients: 1-year interim results of the HCV-3 study.
Liver Transplantation.
13:1521-1531.
2007
|
|
| 2007
|
LAG-3 regulates CD8+ T cell accumulation and effector function in murine self- and tumor-tolerance systems.
Journal of Clinical Investigation.
117:3383-3392.
2007
|
|
| 2007
|
Alterations of the HBP1 transcriptional repressor are associated with invasive breast cancer.
Cancer Research.
67:6136-6145.
2007
|
|
| 2007
|
Timing of return to normal activities after orbital floor fracture repair.
Plastic and Reconstructive Surgery.
120:245-251.
2007
|
|
| 2007
|
Early Prostate Cancer Antigen Expression in Predicting Presence of Prostate Cancer in Men With Histologically Negative Biopsies.
Investigative urology.
177:1736-1740.
2007
|
|
| 2007
|
Distinguishing prostatic from colorectal adenocarcinoma on biopsy samples: The role of morphology and immunohistochemistry.
Archives of Pathology and Laboratory Medicine.
131:599-603.
2007
|
|
| 2007
|
Acute graft-versus-host disease after liver transplantation: Role of withdrawal of immunosuppression in therapeutic management.
Liver Transplantation.
13:157-161.
2007
|
|
| 2006
|
Radiofrequency thermal ablation of hepatocellular carcinoma before liver transplantation - A clinical and histological examination.
Clinical Transplantation.
20:695-705.
2006
|
|
| 2006
|
Renal cell carcinoma associated with prominent angioleiomyoma-like proliferation: Report of 5 cases and review of the literature.
American Journal of Surgical Pathology.
30:1372-1381.
2006
|
|
| 2006
|
Diagnostic molecular pathology: An increasingly indispensable tool for the practicing pathologist.
Archives of Pathology and Laboratory Medicine.
130:1339-1348.
2006
|
|
| 2006
|
Widespread high-grade prostatic intraepithelial neoplasia on prostatic needle biopsy: A significant likelihood of subsequently diagnosed adenocarcinoma.
American Journal of Surgical Pathology.
30:1184-1188.
2006
|
|
| 2006
|
Interobserver agreement in hepatitis C grading and staging and in the Banff grading schema for acute cellular rejection: The "Hepatitis C 3" multi-institutional trial experience.
Archives of Pathology and Laboratory Medicine.
130:1157-1162.
2006
|
|
| 2006
|
Liver and kidney transplantation for polycystic liver and kidney-renal function and outcome.
Transplantation.
82:501-507.
2006
|
|
| 2006
|
Radio-frequency ablation of hepatocellular carcinoma before liver transplantation: A histologic and 'TUNEL' study.
Liver International.
26:746-751.
2006
|
|
| 2006
|
Composite lymphocyte-rich Hodgkin lymphoma and peripheral T-cell lymphoma associated with Epstein-Barr virus: A case report and review of the literature.
Archives of Pathology and Laboratory Medicine.
130:107-112.
2006
|
|
| 2005
|
Acute Graft versus host disease after liver transplantation: Patterns of lymphocyte chimerism.
American Journal of Transplantation.
5:2968-2973.
2005
|
|
| 2005
|
Cadaveric orthotopic auxiliary split liver transplantation and kidney transplantation: An alternative for type 1 primary hyperoxaluria.
Transplantation.
80:421-424.
2005
|
|
| 2005
|
Cutaneous lymphoid hyperplasia and marginal zone B-cell lymphoma following vaccination.
Journal of the American Academy of Dermatology.
53:511-515.
2005
|
|
| 2005
|
Diagnostic molecular pathology, part 2: proteomics and clinical applications of molecular diagnostics in hematopathology..
Baylor University Medical Center Proceedings.
18:7-12.
2005
|
|
| 2005
|
Intratumoral injection of INGN 241, a nonreplicating adenovector expressing the melanoma-differentiation associated gene-7 (mda-7/IL24): Biologic outcome in advanced cancer patients.
Molecular Therapy.
11:160-172.
2005
|
|
| 2004
|
Experimental infection of NOD/SCID mice reconstituted with human CD34 + cells with Epstein-Barr virus.
Journal of Virology.
78:13891-13900.
2004
|
|
| 2004
|
Hepatitis C virus quasi-species dynamics predict progression of fibrosis after liver transplantation.
Journal of Infectious Diseases.
189:2037-2046.
2004
|
|
| 2003
|
The changing clinical presentation of recurrent primary biliary cirrhosis after liver transplantation.
Transplantation.
76:1583-1588.
2003
|
|
| 2003
|
Diagnostic molecular pathology: current techniques and clinical applications, part I..
Baylor University Medical Center Proceedings.
16:379-383.
2003
|
|
| 2003
|
A model to predict severe HCV-related disease following liver transplantation.
Hepatology.
38:34-41.
2003
|
|
| 2003
|
Pilot trial of intravenous infusion of a replication-selective adenovirus (ONYX-015) in combination with chemotherapy or IL-2 treatment in refractory cancer patients.
Cancer Gene Therapy.
10:341-352.
2003
|
|
| 2003
|
Liver transplant-associated graft-versus-host disease.
Transplantation.
75:118-126.
2003
|
|
| 2003
|
Predictors for nonsentinel node involvement in breast cancer patients with micrometastases in the sentinel lymph node..
Baylor University Medical Center Proceedings.
16:3-6.
2003
|
|
| 2003
|
Pretransplant MELD score as a predictor of outcome after liver transplantation for chronic hepatitis C.
American Journal of Transplantation.
3:626-630.
2003
|
|
| 2002
|
Hematologic aspects of liver transplantation for Budd-Chiari syndrome with special reference to myeloproliferative disorders.
Transplantation.
74:1090-1095.
2002
|
|
| 2002
|
Delay of hepatitis C recurrence in liver transplant recipients: Impact of mycophenolate mofetil on transplant recipients with severe acute rejection or with renal dysfunction.
Transplantation Proceedings.
34:1561-1562.
2002
|
|
| 2002
|
Recurrence of hepatitis C in liver transplant recipients treated with mycophenolate mofetil.
Transplantation Proceedings.
34:1563-1564.
2002
|
|
| 2002
|
Incidence and recurrence of autoimmune/alloimmune hepatitis in liver transplant recipients.
Liver Transplantation.
8:519-526.
2002
|
|
| 2001
|
Malabsorption due to cholecystokinin deficiency in a patient with autoimmune polyglandular syndrome type I [1] letters).
New England Journal of Medicine.
345:64-66.
2001
|
|
| 2001
|
Intravenous infusion of a replication-selective adenovirus (ONYX-015) in cancer patients: Safety, feasibility and biological activity
2001
|
|
| 2001
|
Malabsorption due to cholecystokinin deficiency in a patient with autoimmune polyglandular syndrome type I.
New England Journal of Medicine.
344:270-274.
2001
|
|
| 2001
|
Growth-inhibitory effects of CD40 ligand (CD154) and its endogenous expression in human breast cancer.
Clinical Cancer Research.
7:691-703.
2001
|
|
| 2000
|
CD40 ligand-induced apoptosis is Fas-independent in human multiple myeloma cells
2000
|
|
| 2000
|
Fatal graft-versus-host disease associated with solid-organ transplantation.
Blood.
96.
2000
|
|
| 2000
|
Liver transplantation for hepatitis C: Recurrence and disease progression in 300 patients.
Liver Transplantation.
6:553-561.
2000
|
|
| 1999
|
In breast carcinoma tissue, immature dendritic cells reside within the tumor, whereas mature dendritic cells are located in peritumoral areas.
Journal of Experimental Medicine.
190:1417-1425.
1999
|
|
| 1999
|
Detection of low level benzene exposure in supermarket wrappers by urinary muconic acid.
Biomarkers.
4:106-117.
1999
|
|
| 1998
|
Recurrent primary sclerosing cholangitis after orthotopic liver transplantation: Is chronic rejection part of the disease process?.
Transplantation.
66:1300-1306.
1998
|
|
| 1998
|
Long-term outcome of patients transplanted with livers from hepatitis C- positive donors.
Transplantation.
65:925-929.
1998
|
|
| 1998
|
De novo hepatitis B infection after liver transplantation: Source of disease, incidence and impact.
Liver Transplantation.
4:119-127.
1998
|
|
| 1998
|
Protection by cyclosporine a against normothermic liver ischemia- reperfusion in pigs.
Journal of Surgical Research.
75:116-126.
1998
|
|
| 1997
|
Apoptosis induced in advanced CD8F1-murine mammary tumors by the combination of PALA, MMPR and 6AN precedes tumor regression and is preceded by ATP depletion.
Cancer Chemotherapy and Pharmacology.
40:376-384.
1997
|
|
| 1995
|
Changing Pattern of Expression of the Epidermal Growth Factor Receptor and Transforming Growth Factor α in the Progression of Prostatic Neoplasms.
Clinical Cancer Research.
1:545-550.
1995
|
|
| 1995
|
The predictive value of hepatocyte glycogen content on liver allograft biopsy: Correlation with early graft function.
Transplantation.
59:141-143.
1995
|
|
| 1995
|
Prognostic value of p53 nuclear overexpression in patients with invasive bladder cancer treated with neoadjuvant MVAC.
Journal of Clinical Oncology.
13:1384-1390.
1995
|
|
| 1994
|
Molecular biologic aspects of human prostatic carcinoma..
American Journal of Clinical Pathology.
102:S57-S64.
1994
|
|
| 1994
|
Molecular biologic aspects of human prostatic carcinoma.
American Journal of Clinical Pathology.
102.
1994
|
|
| 1993
|
Fat-suppressed three-dimensional MR imaging of the breast.
1993
|
|
| 1993
|
Heterotransplantation of human multiple myeloma cell lines in severe combined immunodeficiency (SCID) mice
1993
|
|
| 1993
|
OKT3 rescue for steroid-resistant rejection in adult liver transplantation.
Transplantation.
55:87-91.
1993
|
|
| 1990
|
Sclerosing mediastieitis: Improved management with histoplasmosis titer and ketoconazole.
Annals of Thoracic Surgery.
50:215-221.
1990
|
|
| 1990
|
Steroid receptors in benign mastectomy tissue.
American Journal of Clinical Pathology.
94:14-17.
1990
|
|
